NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$11.14−0.16 (-1.42%)
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
NovoCure EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
NovoCure's EV/EBITDA was 446.8× on Oct 29, 2021, against 759.2× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Oct 29, 2021 | 446.8× | −182.4 |
| 2020 | Dec 31, 2020 | 629.1× | – |
See a number that looks wrong?